XOMA to Present Preclinical Data from its PTH1R Monoclonal Antibodies Program at the American Association for Cancer Research Annual Meeting Mar 28, 2017 7:00am EDT
XOMA Announces Full Repayment of Hercules Technology Growth Capital Debt Obligation Mar 22, 2017 7:00am EDT
XOMA to Announce Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call Focused on its New Strategic Direction on March 16, 2017 Mar 14, 2017 7:00am EDT
XOMA to Present New Strategic Initiatives at the Cowen and Company 37th Annual Health Care Conference Feb 28, 2017 7:00am EST
XOMA Announces Pricing of $25 Million Registered Offering of Common Stock and Convertible Preferred Stock Feb 13, 2017 7:00am EST
XOMA Establishes Proof-of-Concept for 358 in Congenital Hyperinsulinism and Hypoglycemia Post-Bariatric Surgery Jan 31, 2017 4:00pm EST
XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update Dec 21, 2016 5:00pm EST
